Bal Pharma Limited (NSE:BALPHARMA) — Stock Price

Rs90.90 INR
▲ 1.87% today

Bal Pharma Limited (NSE:BALPHARMA) is currently trading at Rs90.90 INR, up 1.87% today. Over the past 52 weeks, shares have ranged between Rs60.42 and Rs96.43. This page tracks Bal Pharma Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BALPHARMA stock market capitalisation.

Bal Pharma Limited (BALPHARMA) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Bal Pharma Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Bal Pharma Limited Income Statement — Revenue, Profit & Earnings by Year

Bal Pharma Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20262025202420232022
Total Revenue Rs3.12 Billion Rs3.03 Billion Rs3.39 Billion Rs3.04 Billion Rs2.81 Billion
Cost of Revenue Rs2.36 Billion Rs2.43 Billion Rs2.62 Billion Rs1.73 Billion Rs1.70 Billion
Gross Profit Rs761.52 Million Rs730.18 Million Rs770.20 Million Rs1.25 Billion Rs1.11 Billion
Research & Development — Rs32.50 Million Rs50.71 Million Rs49.19 Million Rs32.04 Million
SG&A — Rs46.20 Million Rs42.68 Million Rs34.24 Million Rs27.05 Million
Total Operating Expenses Rs553.28 Million Rs396.01 Million Rs396.65 Million Rs1.08 Billion Rs967.88 Million
Operating Income Rs208.24 Million Rs197.89 Million Rs214.57 Million Rs177.23 Million Rs149.18 Million
EBITDA Rs319.03 Million Rs317.63 Million Rs320.23 Million Rs245.00 Million Rs239.71 Million
EBIT Rs208.24 Million Rs219.92 Million Rs219.52 Million Rs153.72 Million Rs149.31 Million
Interest Expense Rs168.18 Million Rs168.54 Million Rs152.58 Million Rs106.23 Million Rs105.42 Million
Income Before Tax Rs59.34 Million Rs51.38 Million Rs90.47 Million Rs47.48 Million Rs91.83 Million
Income Tax Expense Rs-3.86 Million Rs-20.99 Million Rs16.02 Million Rs21.29 Million Rs34.77 Million
Net Income Rs62.84 Million Rs72.15 Million Rs73.92 Million Rs25.72 Million Rs56.12 Million

Bal Pharma Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Bal Pharma Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20262025202420232022
Total Assets Rs3.76 Billion Rs3.36 Billion Rs3.20 Billion Rs3.13 Billion Rs2.61 Billion
Total Current Assets Rs2.62 Billion Rs2.35 Billion Rs2.34 Billion Rs2.28 Billion Rs1.85 Billion
Cash & Equivalents — Rs80.50 Million Rs132.92 Million Rs14.87 Million Rs11.13 Million
Short-term Investments Rs20.82 Million Rs86.59 Million Rs157.33 Million Rs59.76 Million Rs41.08 Million
Net Receivables Rs947.98 Million Rs935.76 Million Rs996.22 Million Rs974.93 Million Rs828.67 Million
Inventory Rs1.16 Billion Rs1.03 Billion Rs878.11 Million Rs980.05 Million Rs743.96 Million
Property, Plant & Equipment — Rs737.76 Million Rs620.77 Million Rs621.79 Million Rs571.85 Million
Goodwill Rs38.27 Million Rs38.27 Million Rs38.29 Million Rs38.29 Million Rs38.29 Million
Total Liabilities Rs2.93 Billion Rs2.58 Billion Rs2.50 Billion Rs2.49 Billion Rs2.02 Billion
Total Current Liabilities Rs2.49 Billion Rs2.20 Billion Rs2.03 Billion Rs2.09 Billion Rs1.66 Billion
Long-term Debt Rs318.85 Million Rs314.13 Million Rs363.82 Million Rs305.23 Million Rs270.13 Million
Net Debt Rs1.52 Billion Rs1.42 Billion Rs1.38 Billion Rs1.30 Billion Rs1.06 Billion
Total Stockholder Equity Rs822.27 Million Rs774.16 Million Rs692.94 Million Rs637.89 Million Rs586.27 Million
Retained Earnings — Rs273.10 Million Rs217.93 Million Rs146.88 Million Rs135.81 Million

Bal Pharma Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Bal Pharma Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20262025202420232022
Operating Cash Flow Rs144.72 Million Rs42.32 Million Rs228.06 Million Rs-18.43 Million Rs277.08 Million
Capital Expenditures Rs185.55 Million Rs187.87 Million Rs109.80 Million Rs146.45 Million Rs84.69 Million
Free Cash Flow Rs-40.83 Million Rs-145.55 Million Rs118.26 Million Rs-164.89 Million Rs192.39 Million
Investing Cash Flow Rs-215.41 Million Rs-156.53 Million Rs-188.91 Million Rs-221.82 Million Rs-94.85 Million
Financing Cash Flow Rs72.26 Million Rs90.12 Million Rs-12.06 Million Rs244.00 Million Rs-181.34 Million
Dividends Paid Rs19.11 Million Rs19.11 Million Rs15.69 Million Rs15.57 Million Rs14.82 Million
Stock-Based Compensation Rs0.00 Rs0.00 Rs0.00 Rs0.00 Rs9.13 Million
Depreciation Rs110.79 Million Rs97.71 Million Rs100.71 Million Rs91.28 Million Rs90.40 Million
Change in Cash Rs53.50 Million Rs37.35 Million Rs27.09 Million Rs3.74 Million Rs893.00K

Bal Pharma Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Bal Pharma Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 27, 2026 — — —
Feb 11, 2026 — — —
Nov 12, 2025 — — —
Aug 11, 2025 — — —
May 26, 2025 — — —
Feb 10, 2025 — — —
Nov 06, 2024 — — —